When to Increase Your Mounjaro Dose — and How the Process Works

Step 1, Why the titration ladder exists in the first place

A lot of people assume they should feel the full effect of Mounjaro from their very first pen. That's a common and understandable expectation, but it's not how the medicine is designed. The 2.5mg starting dose is there to let your digestive system adapt to a new mechanism, two gut-hormone receptors (GIP and GLP-1) being activated simultaneously for the first time. Nausea, reflux and changes in appetite are much easier to manage at 2.5mg than they would be if treatment opened at a higher level.

The NHS tirzepatide medicines page describes this incremental approach clearly: the dose steps up gradually, giving the body time to adjust at each rung before moving higher. Most of the clinical evidence for weight loss, including data from the SURMOUNT-1 trial, was gathered at doses of 10mg and 15mg, which is where sustained therapeutic effect typically becomes most pronounced. Getting there safely takes time by design, not by accident.

If you want a fuller picture of why dose increases matter for weight loss outcomes, that question has its own dedicated page, it goes deeper into the mechanism behind each step.

Step 2, The four-week minimum and what 'ready' actually means

The standard guidance is a minimum of four weeks at each dose before considering an increase. Four weeks is not a guarantee of progression, it is the earliest point at which a clinical review makes sense. Your prescriber is looking at two things: first, whether side effects have settled enough that a higher dose is tolerable; second, whether the current dose still appears to be doing useful work or has plateaued.

Tolerability is the primary gate. If nausea, stomach discomfort or other gastrointestinal effects are still significant at week four, staying at the current dose for longer is entirely appropriate. There is no clinical penalty for a slower ascent, many people spend six or eight weeks at a given dose before moving up, and that is completely normal practice. Rushing the ladder to reach 15mg faster does not produce better results and often leads to worse side effects.

Weight response matters too, but it is rarely the sole signal. A plateau after several months at the highest tolerated dose is a different situation from being four weeks into 5mg, and our page on when to increase your tirzepatide dose can help you understand the timing before you speak to your prescriber. The clinical signals that point to a dose review are worth understanding in detail before your next check-in.

Step 3, What the prescriber review actually looks at

At each repeat, a prescriber is not simply ticking a box. They are checking that your current dose is both safe to continue and appropriately serving your treatment goals. At nume, a named clinician reads your update before any repeat pen is dispensed, the same-day clinical review our prescribers carry out is part of every order, not just the first one.

Relevant information includes: which side effects you have experienced and whether they have eased, your current weight relative to your starting point, any new medicines or health changes since your last order, and whether the dose step you are requesting aligns with the titration schedule. Transfer patients and anyone requesting a dose increase provide evidence of their current treatment as part of this process.

NICE's appraisal of tirzepatide (TA1026) includes a note that continuing treatment should be reviewed if weight loss is less than 5% after six months at the highest tolerated dose. That is a clinical threshold your prescriber can apply, not one to self-assess. If you have questions about what to expect physically when the dose goes up, that page covers the adjustment period in practical terms.

Step 4, The doses themselves, and what 'maintenance' looks like

After the 2.5mg starter, the sequence runs through 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Not everyone reaches 15mg, and not everyone needs to. Some people find a dose (sometimes called a golden dose) where appetite control is strong and side effects are minimal, and they stay there rather than pressing higher. That is a legitimate clinical outcome, not a failure to complete a course.

The highest dose studied in SURMOUNT-1 was 15mg, where average body-weight reductions of around 20–21% were recorded over 72 weeks. Reaching that figure is not the target for every person, the target is the dose that produces meaningful, sustainable benefit without unacceptable side effects for you specifically.

Cost is a real consideration for many people on private treatment. How Mounjaro is priced in the UK by dose is laid out on our pricing page, so you can plan ahead as titration progresses. And if you are weighing up how the Mounjaro titration experience compares with other GLP-1 approaches, the weight-loss treatment overview gives a balanced starting point.

When you feel ready to talk through your next step with a prescriber, check your eligibility and start a free consultation, a clinician will review your situation and advise on the right pace for you.